Merrimack Pharmaceuticals, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023
November 02, 2023 at 04:30 pm EDT
Merrimack Pharmaceuticals, Inc. reported earnings results for the third quarter and nine months ended September 30, 2023. For the third quarter, the company reported net loss was USD 0.279 million compared to USD 0.442 million a year ago. Basic loss per share from continuing operations was USD 0.02 compared to USD 0.03 a year ago.
For the nine months, net loss was USD 0.941 million compared to USD 1.05 million a year ago. Basic loss per share from continuing operations was USD 0.07 compared to USD 0.08 a year ago.